U.S. markets closed

Medifast, Inc. (MED)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
294.84+16.52 (+5.94%)
At close: 4:00PM EDT

294.00 -0.84 (-0.28%)
After hours: 7:49PM EDT

Sign in to post a message.
  • w
    "Also during the first quarter of 2021, the company used $7.5 million to repurchase shares of common stock and there are approximately 2.3 million shares remaining under the company's stock repurchase program."
  • E
    Ex-Pathological Liar In Chief
    Not much activity on this board. Anyone else catch the breakout in MED today? Great move; great profits so far!!
  • w
    Geez, why do they spoil me so?

    o Revenue increased 90.9% to $340.7 million
    o Net income increased 122.2% to $41.1 million
    o Earnings per diluted share ("EPS") of $3.46, an increase of 121.8%
  • a
    They had some interesting insights about MED on (http://Stocks-tracker.com). Definitely made me think twice about the company.
  • w
    30% revenue growth, 40% earnings growth, debt-free, cash-rich, and a 25% dividend hike to boot... honestly, is there another stock that offers this??
  • m
    Diamond in the rough. Picked up some more shares at $221 today. Please continue to fall so I can build this one into a massive position!
  • w
  • m
    I believe there were a lot of sellers in the market the last 30 days due to last years crash. Many people taking long term profits on the massive market recovery over the last 12 months.
  • Y
    Yahoo Finance Insights
    Medifast is up 12.45% to 253.01
  • w
    Full Year 2020 Highlights Compared to the Prior-Year Period

    - Revenue of $934.8 million, an increase of 31.0% year-over-year
    - Net income of $102.9 million, an increase of 32.0% year-over-year
    - Non-GAAP adjusted net income increased 38.9% to $108.3 million
    - EPS of $8.68, an increase of 35.0% year-over-year
    - Non-GAAP adjusted EPS of $9.14, a 42.1% increase
    - Cash, cash equivalents and investment securities of $174.5 million and the company remains free of interest-bearing debt as of December 31, 2020
  • J
    can't understand why this drops so much
  • w
    Remarkable how far short interest has dropped... Looking forward to the surging growth reflected in a stock of less than 12 million shares...
  • V
    that is strange that people are unhappy by MED results
  • K
    Kevin Hersh
    I just came back from the MED OPTAVIA conference. The new system for guiding people is so focused and attainable by so many looking for a healthier body, mindset and financial future. There’s a lot of science and common sense here. 11k+ coaches were there, next year it will double again. I’m doubling my client base and doubling my position in this company. So much future growth is coming. #ALLIN
  • H
    I'm a first time buyer of MED today. I've watched this for several months, waiting for what I felt was a reasonable technical entry point. Louie Navellier has recommended this stock several times, and MED has been on his buy list for his subscription clients for a long time. I see some chart resistance around $140, and then more around $158. The fundamentals (which are very strong on all metrics) will take over, and eventually that resistance will be overcome. The only issue I see is how thinly traded the stock is. With a low float and low daily volume, the bid/ask spreads are huge. Shorts don't bother me at all, I'm short other stocks. I think they're crazy to short a stock with a 10M float, but that's me. So I may not post too much, but I'm not going anywhere for awhile. I also plan to add on any pullbacks.
  • N
    Why is no one talking about this stock? I'm mostly in computer tech, but this stock has outpaced everything else in my portfolio! Got in at $110 and again at $155. Does anyone have a price target? Keeps going up and up!
  • j
    12M. Shares OS Only! I'd be VERY careful if I were shorting this.. they have NO DEBT and pay dividends and increased their guidance...
  • E
    Why is MED valued so low?
    Analysts expecting 20% EPS growth but the PE is only 14-15.
    Debt to Equity 0,12. Debt to EBITDA 0,13. Cash to Debt 8,22 ... so basically no debt.

    Am I missing something but is this a debt-free, strong growing company which is actually pretty undervalued?
  • I
    Everything better than expected. Stock is easily valued over $200. Some large fund managers sold so the stock is down temporarily. Should rebound fast.
  • B
    Looks like earnings were too good. The growth is too good too. They are expanding into Singapore and Hong.
    Something is wrong. That something is
    1) Analyst buddies need to cover their short positions
    2) There are too
    Many today which are moving
    3) you guys pumped every board and that is the reaction.

    I will buy sometime tomorrow